Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct-acting Antiviral Agents”

147 trials

Showing 20 of 147 results

Post-approval studies (Phase 4)UnknownNCT04267458
What this trial is testing

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

Who this might be right for
Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment
Cairo University 300
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Post-approval studies (Phase 4)Study completedNCT04457050
What this trial is testing

Effect of Hepatitis C Clearance on Insulin Resistance

Who this might be right for
Insulin ResistanceHepatitis C
Alexandria University 160
Not applicableUnknownNCT03481036
What this trial is testing

DAA Therapy in Pediatric Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis c
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Large-scale testing (Phase 3)UnknownNCT03163849
What this trial is testing

Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 50
Not applicableStudy completedNCT02969668
What this trial is testing

Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients

Who this might be right for
Hepatitis C, ChronicOpioid-Related Disorders
Universitätsklinikum Hamburg-Eppendorf 326
Post-approval studies (Phase 4)WithdrawnNCT03623568
What this trial is testing

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

Who this might be right for
Kidney FailureKidney DiseasesHepatitis C
Raymond T. Chung, MD
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Not applicableStudy completedNCT06829966
What this trial is testing

Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

Who this might be right for
Intestinal Microbiota Between Different Groups
Assiut University 30
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01508130
What this trial is testing

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 672
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Not applicableStudy completedNCT04047680
What this trial is testing

EGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

Who this might be right for
Hepatitis CRenal DiseaseViral Hepatitis C
National Taiwan University Hospital 441
Not applicableLooking for participantsNCT06928259
What this trial is testing

Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

Who this might be right for
HCV Infection
University of Seville 728
Not applicableUnknownNCT03775798
What this trial is testing

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Who this might be right for
Hepatitis CCirrhosisAntiviral Drug Adverse Reaction
Austral University, Argentina 2,200
Not applicableUnknownNCT04952207
What this trial is testing

Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Qing XIe 300
Not applicableUnknownNCT03414554
What this trial is testing

Risk of HCC in Cirrhotic Patients Post DAAs Ttt

Who this might be right for
HCC
Assiut University 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation